Nucleotide probes and method for determining hla dqb1 typing
CA 2257182 A1 · Owner: Bio Merieux · Inventors: Mougin, Bruno
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Nucleotide probe selected in particular among the following: TG <u>CGT TAT GTG ACC AGA</u> GT<u>G CGT CTT GTG ACC AGA</u>, GT <u>CTT GTA ACC AGA CAC</u> AT CG<u>T CTT GTA ACC AGA TAC</u> AT, CG<u>T CTT GTG AGC AGA AGC</u> AT CG <u>ACC GAG CTC GTG CGG CG</u>T G, G T<u>AC CGG GCA GTG AC</u>G C G A<u>CG CCG CTG GGI CCG CCT G</u>, G A<u>CG CCG CTG GGG CCG CCT G</u> G G<u>AG GGI ACC CIG GCI GA</u>G T, G G<u>AG GGG ACC CGG GCG GA</u>G T TC<u>G GTG GAC ACC GTA TGC AG</u>A C, GG <u>ACG GAG CGC GTG </u>CG C <u>ATC TAT AAC CGA GA</u>, and their complementary sequences being understood that the said probes have at least the underlined sequence and can further contain one or two bases selected …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 3, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 3, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 3, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.